fda stop tirzepatide Grants a New Indication for Obesity Management Tirzepatide Wins FDA Approval for

Follow up and adjustments What to Expect Weeks 2 to 4: cravings soften and blood sugar swings may begin to improve Weeks 4 to 8: weight begins to trend down as appetite and portions stabilize Weeks 12 and beyond: many patients see significant improvements in weight, waist measurements, and energy FAQs Tirzepatide acts on both GIP and GLP-1 receptors, which provides an additional layer of metabolic support

Youve seen the demand

Inability to identify pharmacy partners suggests either a lack of oversight or deliberate opacity

Novo Nordisk expects a US launch in early January 2026 (Novo Nordisk press release, 2025) If you want more information on the newly approved Wegovy tablet, see our guide to Wegovy pills

Most side effects, though, are usually temporary and improve as your body adjusts